Popular Articles

Cylene To Announce New Data On Its First-in-Class Oral CK2 Inhibitor Against Cancer At BIO Conference
Cylene Pharmaceuticals, Inc., announced that it will present major advances in the development of their first-in-class, CK2 inhibitor CX-4945 at the 2009 BIO International Convention on Wednesday, May 20th at 4:40 pm. William G. Rice, Ph.D., Cylene"s president and CEO, will discuss the mechanism, antitumor properties and tumor selectivity of CX-4945, the Company"s oral protein kinase inhibitor currently in Phase I clinical trials. This proprietary compound has demonstrated promise as a potent and selective oral inhibitor of protein kinase CK2, a previously unexploited molecular target with well documented roles in many cancers, indicating broad therapeutic potential. Cylene"s Serine/Threonine Kinase Inhibitor program has also delivered orally active pan-PIM inhibitors of the PIM-1,2,3 kinases, still in pre-clinical development.
new payday loan lenders
Multiple Sclerosis Treatment Pioneer's Helium Suicide
Police are investigating the suicide of an academic who pioneered treatment for multiple sclerosis but could no longer live with the disease herself.
News of the day
White House: Opponents Misrepresent End-Of-Life Issue In Reform Debate
The White House says opponents of the President"s health care reform effort are misrepresenting parts of the House and Senate legislation including a provision on end-of-life care. Critics say they fear health care reform could lead to excessive government intervention in end-of-life issues.
Endocrinology

President Obama Announces Nominee For Surgeon General

President Barack Obama announced his intent to nominate Regina M. Benjamin as Surgeon General, Department of Health and Human Services. President Obama said, "Health care reform is about every family"s health and the health of our economy. And if there"s anyone who understands the urgency of meeting this challenge in a personal and powerful way, it"s the woman who will become our nation"s next Surgeon General, Doctor Regina Benjamin. I look forward working with her in the months and years ahead." President Obama announced his intent to nominate the following individual today: Regina M. Benjamin, Nominee for Surgeon General, Department of Health and Human Services Regina M. Benjamin, MD, MBA, is Founder and CEO of the Bayou La Batre Rural Health Clinic in Bayou La Batre, Alabama. She is the Immediate Past-Chair of the Federation of State Medical Boards of the United States, and previously served as Associate Dean for Rural Health at the University of South Alabama College of Medicine. In 2002, she became President of the Medical Association of the State of Alabama, making her the first African American woman to be president of a State Medical Society in the United States. Dr. Benjamin holds a BS in Chemistry from Xavier University, New Orleans. She was in the 2nd class at Morehouse School of Medicine and received her MD degree from the University of Alabama, Birmingham, as well as an MBA from Tulane University. She completed her residency in family medicine at the Medical Center of Central Georgia. Dr. Benjamin received the Nelson Mandela Award for Health and Human Rights in 1998, and was elected to the American Medical Association Board of Trustees in 1995, making her the first physician under age 40 and the first African-American woman to be elected. Dr. Benjamin was previously named by Time Magazine as one of the "Nation"s 50 Future Leaders Age 40 and Under." She was also featured in a New York Times article, "Angel in a White Coat", as "Person of the Week" on ABC"s World News Tonight with Peter Jennings, and as "Woman of the Year" by CBS This Morning. She received the 2000 National Caring Award which was inspired by Mother Teresa, as well as the papal honor Pro Ecclesia et Pontifice from Pope Benedict XVI. She is also a recent recipient of the MacArthur Genius Award. The White House


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):